Massivemarkets

NRXP

NRX Pharmaceuticals, Inc. Common Stock

Nasdaq · usd

$2.15-0.40 (-15.70%)
At close · 15-minute delayed
$2.23+0.08 (+3.69%)
As of 7:58:20 PM EST on Nov 20, 2026 · After hours

NRX Pharmaceuticals, Inc. Common Stock (NRXP) trades at $2.15 (-15.70%) as of 7:58:20 PM EST on Nov 20, 2026, -10.42% over the past month. Market cap is $95.31M, with 4.6 days to cover in short interest.

Stock performance

How NRX Pharmaceuticals, Inc. Common Stock (NRXP) stock has performed from one day to one year, with its 52-week range.

-10.47%
-$0.26 over 1D
$2.17$2.29$2.40$2.514:00 AM10:40 AM12:45 PM2:55 PM8:00 PM$2.23
1D
-15.69%
1W
-1.83%
1M
-10.42%
YTD
-20.66%
1Y
-4.02%
52-wk range
$1.62 – $5.06

Key statistics

Today's trading snapshot for NRXP: day range, open, previous close, volume and market cap.

Day range
$2.14 – $2.53
Open
$2.53
Prev close
$2.55
Volume
1.48M
Market cap
$95.31M
Shares out
43.65M

Valuation and profitability ratios: P/E, P/S, ROE

Valuation and profitability ratios for NRX Pharmaceuticals, Inc. Common Stock: P/E, P/S, P/B, ROE and more.

P/E
—
P/S
22.11
P/B
-47.99
P/FCF
—
ROE
995.2%
ROA
-71.1%
Debt/Equity
-0.13
Div yield
0.00%

As of Nov 20, 2026

8-K filings

Material corporate events NRX Pharmaceuticals, Inc. Common Stock has disclosed to the SEC on Form 8-K.

  • On October 30, 2026, NRx Pharmaceuticals, Inc. (the "Company") announced that the U.S. Food and Drug Administration (the "FDA") has approved the Company's Abbreviated New Drug Application ("ANDA") for Preservative-Free Ketamine, ahead of the November 10, 2026 goal date established under the Generic Drug User Fee Amendments ("GDUFA").

  • Shareholder meeting noticeOct 16, 2026

    On October 16, 2026, the board of directors (the "Board") of NRx Pharmaceuticals, Inc. (the "Company") established December 17, 2026 as the date of the 2026 Annual Meeting of Stockholders (the "2026 Annual Meeting") and set October 28, 2026 as the record date for determining stockholders entitled to vote at the 2026 Annual Meeting. The 2026 Annual Meeting will be held at 10:00 a.m., Eastern Time, in a virtual-only format conducted by live webcast.

  • The clinical trial has been approved by the U.S. Food and Drug Administration and is expected to begin enrolling patients.

  • On September 15, 2026, NRx Pharmaceuticals, Inc. (the "Company") issued a press release announcing that it has received a written communication from the Director of Regulatory Operations of the FDA Office of Generic Drugs advising the Company that the amendment to its Abbreviated New Drug Application (ANDA), previously classified as a Major Amendment, has been reclassified as a Minor Amendment.

  • Investor presentationSep 14, 2026

    On September 8, 2026, representatives of NRx Pharmaceuticals, Inc. (the "Company") used the investor presentation furnished as Exhibit 99.1 to this Current Report on Form 8-K in connection with presentations and meetings with investors and other persons. The Company may continue to use the investor presentation, in whole or in part, and possibly with modifications, in connection with presentations to investors, analysts and other persons.

Dividend history and stock splits

NRX Pharmaceuticals, Inc. Common Stock's recent dividend payments and stock splits.

Dividends

No recent dividends.

Splits

  • 1-for-10Apr 2, 2024

NRXP short interest

How heavily NRXP is shorted: shares short, days to cover and average daily volume.

Days to cover
4.6
Short interest
10.46M
Avg volume
2.29M

As of · reported to FINRA twice monthly.

NRXP news

The latest news and headlines about NRX Pharmaceuticals, Inc. Common Stock (NRXP).

Frequently asked questions

What is the NRX Pharmaceuticals, Inc. Common Stock (NRXP) stock price today?

NRX Pharmaceuticals, Inc. Common Stock (NRXP) is trading at $2.15 (-15.70% on the day) as of 7:58:20 PM EST on Nov 20, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

What is NRX Pharmaceuticals, Inc. Common Stock?

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases.

What is the short interest in NRXP?

As of Oct 30, 2026, NRXP has 10.46M shares short and 4.6 days to cover.

What exchange is NRXP listed on?

NRX Pharmaceuticals, Inc. Common Stock (NRXP) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.

Build with AI

Build an analysis of NRXP with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a NRXP analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.